Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000315066-24-002693
Filing Date
2024-11-12
Accepted
2024-11-12 09:55:14
Documents
1

Document Format Files

Seq Description Document Type Size
1 filing.txt SC 13G/A 6557
  Complete submission text file 0000315066-24-002693.txt   8177
Mailing Address 245 SUMMER STREET BOSTON MA 02210
Business Address 245 SUMMER STREET BOSTON MA 02210 6175706339
FMR LLC (Filed by) CIK: 0000315066 (see all company filings)

EIN.: 043532603 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 0000

Mailing Address 1715 38TH ST BOULDER CO 80301
Business Address 1715 38TH ST BOULDER CO 80301 720-262-7002
Edgewise Therapeutics, Inc. (Subject) CIK: 0001710072 (see all company filings)

EIN.: 821725586 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-92424 | Film No.: 241444503
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)